MiMedx Group (MDXG) Projected to Post Earnings on Wednesday

MiMedx Group (NASDAQ:MDXG) is projected to release its earnings data after the market closes on Wednesday, February 26th. Analysts expect MiMedx Group to post earnings of $0.07 per share and revenue of $89.42 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

MiMedx Group Price Performance

NASDAQ MDXG opened at $7.95 on Tuesday. The firm’s fifty day simple moving average is $8.81 and its two-hundred day simple moving average is $7.67. The company has a current ratio of 4.10, a quick ratio of 3.53 and a debt-to-equity ratio of 0.10. MiMedx Group has a 12-month low of $5.47 and a 12-month high of $10.14. The firm has a market capitalization of $1.17 billion, a P/E ratio of 14.45 and a beta of 1.94.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.